INS and type 2 diabetes mellitus: In animal models, AT DPP4 gene deletion is associated with the regression of VAT inflammation and improved glucose/insulin metabolism, though, so far, no specific cardio-metabolic protection in T2DM individuals chronically treated with DPP4-Is has been shown [144].